Cargando…
Drugs and Targets in Fibrosis
Fibrosis contributes to the development of many diseases and many target molecules are involved in fibrosis. Currently, the majority of fibrosis treatment strategies are limited to specific diseases or organs. However, accumulating evidence demonstrates great similarities among fibroproliferative di...
Autores principales: | Li, Xiaoyi, Zhu, Lixin, Wang, Beibei, Yuan, Meifei, Zhu, Ruixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703866/ https://www.ncbi.nlm.nih.gov/pubmed/29218009 http://dx.doi.org/10.3389/fphar.2017.00855 |
Ejemplares similares
-
Dr AFC: drug repositioning through anti-fibrosis characteristic
por: Wu, Dingfeng, et al.
Publicado: (2020) -
Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023) -
Multipronged Therapeutic Effects of Chinese Herbal Medicine Qishenyiqi in the Treatment of Acute Myocardial Infarction
por: Wang, Yong, et al.
Publicado: (2017) -
Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021) -
Drugs for treating myocardial fibrosis
por: Ren, Zhanhong, et al.
Publicado: (2023)